01 7Trajenta
02 1Trajenta / Jentadueto
03 3Trajenta/ Jentadueto
04 3Trajenta/Jentadueto
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 1,801
2019 Revenue in Millions : 1,857
Growth (%) : -3
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 359
2019 Revenue in Millions : 591
Growth (%) : -39
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 1,709
2020 Revenue in Millions : 1,801
Growth (%) : 3
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 373
2020 Revenue in Millions : 359
Growth (%) : 4
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 1,846
2021 Revenue in Millions : 1,709
Growth (%) : 8
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 1,816
2022 Revenue in Millions : 1,846
Growth (%) : 0
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 329
2014 Revenue in Millions : 357
Growth (%) : 9%
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 1,196
2015 Revenue in Millions : 964
Growth (%) : 24
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 1,579
2017 Revenue in Millions : 1,506
Growth (%) : 5%
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 1,699
2018 Revenue in Millions : 1,523
Growth (%) : 12
LOOKING FOR A SUPPLIER?